- Home
- ABR vs XENE Comparison
ABR vs XENE Comparison
Compare ABR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABR
- XENE
- Stock Information
- Founded
- ABR 2003
- XENE 1996
- Country
- ABR United States
- XENE Canada
- Employees
- ABR N/A
- XENE N/A
- Industry
- ABR Real Estate Investment Trusts
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- ABR Real Estate
- XENE Health Care
- Exchange
- ABR Nasdaq
- XENE Nasdaq
- Market Cap
- ABR 2.7B
- XENE 3.0B
- IPO Year
- ABR 2004
- XENE 2014
- Fundamental
- Price
- ABR $14.51
- XENE $40.14
- Analyst Decision
- ABR Hold
- XENE Strong Buy
- Analyst Count
- ABR 6
- XENE 10
- Target Price
- ABR $14.25
- XENE $57.30
- AVG Volume (30 Days)
- ABR 2.5M
- XENE 406.8K
- Earning Date
- ABR 11-01-2024
- XENE 11-12-2024
- Dividend Yield
- ABR 11.80%
- XENE N/A
- EPS Growth
- ABR N/A
- XENE N/A
- EPS
- ABR 1.35
- XENE N/A
- Revenue
- ABR $650,354,000.00
- XENE N/A
- Revenue This Year
- ABR N/A
- XENE N/A
- Revenue Next Year
- ABR N/A
- XENE $1,600.08
- P/E Ratio
- ABR $10.80
- XENE N/A
- Revenue Growth
- ABR N/A
- XENE N/A
- 52 Week Low
- ABR $11.77
- XENE $28.20
- 52 Week High
- ABR $16.35
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- ABR 41.61
- XENE 39.82
- Support Level
- ABR $14.37
- XENE $37.34
- Resistance Level
- ABR $14.90
- XENE $44.61
- Average True Range (ATR)
- ABR 0.40
- XENE 1.71
- MACD
- ABR -0.08
- XENE -0.58
- Stochastic Oscillator
- ABR 16.19
- XENE 22.98
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.